| Today, Mon, Nov 23, 2009 | | • | Israel Stocks: Tel Aviv broadly higher; Israel Chemicals in focus
at MarketWatch (Mon 9:09am)
| | • | Five Fast-Growing Stocks to Buy
at TheStreet.com (Mon 5:00am)
| | Sun, Nov 22, 2009 | | • | Israel Stocks: Israel stocks steady; BarCap sees no rate change
at MarketWatch (Sun 8:37am)
| | Thu, Nov 19, 2009 | | • | Pfizer's Generic Growth, With a Side of Sashimi
at Motley Fool (Thu, Nov 19)
| | • | Momenta rises on upgrade ahead of Lovenox ruling
AP (Thu, Nov 19)
| | • | Moody's gives negative view on pharma credit
AP (Thu, Nov 19)
| | • | Harvard Endowment Favors Mix of ETFs, International Names
Indie Research (Thu, Nov 19)
| | Wed, Nov 18, 2009 | | • | 5-Star Manager's Global Stock Picks
at CNBC (Wed, Nov 18)
| | • | Israel Stocks: Israel benchmarks steady; Elbit, Formula report
at MarketWatch (Wed, Nov 18)
| | Tue, Nov 17, 2009 | | • | American Funds' Achilles' Heel
at Motley Fool (Tue, Nov 17)
| | • | Israel Stocks: Israel stocks up; Citi calls 0.25%-point rate rise
at MarketWatch (Tue, Nov 17)
| | • | Are You Ready to Make Real Money?
at Motley Fool (Tue, Nov 17)
| | Mon, Nov 16, 2009 | | • | Israel Stocks: Israel stocks steady; Cellcom off after report
at MarketWatch (Mon, Nov 16)
| | • | Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza
at Seeking Alpha (Mon, Nov 16)
| | • | Five Fast-Growing Stocks to Own
at TheStreet.com (Mon, Nov 16)
| | Fri, Nov 13, 2009 | | • | When Big Tax Breaks Aren't Worth the Hassle
at Motley Fool (Fri, Nov 13)
| | Thu, Nov 12, 2009 | | • | Cephalon, Barr settle Fentora dispute
AP (Thu, Nov 12)
| | • | The Life-and-Death Situation That Isn't
at Motley Fool (Thu, Nov 12)
| | • | Powerfully Performing ADRs
at Motley Fool (Thu, Nov 12)
| | • | What Pfizer, KKR and Goldman (Reportedly) Want: Generics!
at The Wall Street Journal Online (Thu, Nov 12)
|
Add TEVA News to My Yahoo!:
 
| |
|
1.29% Nasdaq 
Headlines
